Company Accounts and Tax Online 11288434 Board of Directors 1.5.24 30.4.25 30.4.25 No description of principal activity false iso4217:GBP xbrli:pure 11288434 2023-05-01 2024-04-30 11288434 2025-04-30 11288434 2024-05-01 2025-04-30 11288434 2024-04-30 11288434 countries:EnglandWales 2024-05-01 2025-04-30 11288434 curr:PoundSterling 2024-05-01 2025-04-30 11288434 uk-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 11288434 uk-bus:FRS102 2024-05-01 2025-04-30 11288434 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 11288434 uk-bus:FullAccounts 2024-05-01 2025-04-30 11288434 uk-bus:RegisteredOffice 2024-05-01 2025-04-30 11288434 uk-bus:Director1 2024-05-01 2025-04-30 11288434 uk-bus:Director1 2024-05-01 11288434 uk-bus:Director1 2025-04-30 11288434 core:AfterOneYear 2025-04-30 11288434 core:AfterOneYear 2024-04-30 11288434 core:WithinOneYear 2025-04-30 11288434 core:WithinOneYear 2024-04-30 11288434 core:WithinOneYear 2024-05-01 2025-04-30 11288434 core:AfterOneYear 2025-04-30 11288434 core:AfterOneYear 2024-04-30 11288434 core:AfterOneYear 2024-05-01 2025-04-30 11288434 core:ShareCapital 2025-04-30 11288434 core:ShareCapital 2024-04-30 11288434 core:RevaluationReserve 2025-04-30 11288434 core:RevaluationReserve 2024-04-30 11288434 core:RetainedEarningsAccumulatedLosses 2025-04-30 11288434 core:RetainedEarningsAccumulatedLosses 2024-04-30 11288434 1 2024-05-01 2025-04-30 11288434 core:LandBuildings 2024-05-01 2025-04-30 11288434 core:LandBuildings 2025-04-30 11288434 core:LandBuildings 2023-05-01 2024-04-30 11288434 core:LandBuildings 2024-04-30 11288434 core:PlantMachinery 2024-05-01 2025-04-30 11288434 core:PlantMachinery 2025-04-30 11288434 core:PlantMachinery 2023-05-01 2024-04-30 11288434 core:PlantMachinery 2024-04-30 11288434 core:FurnitureFittingsToolsEquipment 2024-05-01 2025-04-30 11288434 core:FurnitureFittingsToolsEquipment 2025-04-30 11288434 core:FurnitureFittingsToolsEquipment 2023-05-01 2024-04-30 11288434 core:FurnitureFittingsToolsEquipment 2024-04-30 11288434 core:OfficeEquipment 2024-05-01 2025-04-30 11288434 core:OfficeEquipment 2025-04-30 11288434 core:OfficeEquipment 2023-05-01 2024-04-30 11288434 core:OfficeEquipment 2024-04-30 11288434 core:Vehicles 2024-05-01 2025-04-30 11288434 core:Vehicles 2025-04-30 11288434 core:Vehicles 2023-05-01 2024-04-30 11288434 core:Vehicles 2024-04-30 11288434 core:NetGoodwill 2024-05-01 2025-04-30 11288434 core:NetGoodwill 2025-04-30 11288434 core:NetGoodwill 2023-05-01 2024-04-30 11288434 core:NetGoodwill 2024-04-30 11288434 core:IntangibleAssetsOtherThanGoodwill 2024-05-01 2025-04-30 11288434 core:IntangibleAssetsOtherThanGoodwill 2025-04-30 11288434 core:IntangibleAssetsOtherThanGoodwill 2023-05-01 2024-04-30 11288434 core:IntangibleAssetsOtherThanGoodwill 2024-04-30

# AMROZ PHARM LIMITED

## Company Registration Number:
11288434 (England and Wales)

## Unaudited statutory accounts for the year ended 30 April 2025

## Period of accounts

## Start date: 01 May 2024

## End date: 30 April 2025

# AMROZ PHARM LIMITED

## Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Additional notes - 8 |
Balance sheet notes - 11 |

# AMROZ PHARM LIMITED

## Company Information

for the Period Ended 30 April 2025

Director: |  | Roza Imill Zobedey
Registered office: |  | 17 Rosemary Avenue London GBR N9 8QX
Company Registration Number: |  | 11288434 (England and Wales)

# AMROZ PHARM LIMITED

## Directors' Report Period Ended 30 April 2025

The directors present their report with the financial statements of the company for the period ended 30 April 2025

Directors

The directors shown below have held office during the whole of the period from 01 May 2024 to 30 April 2025
Roza Imill Zobedey

This report was approved by the board of directors on 7 October 2025
And Signed On Behalf Of The Board By:

Name: Roza Imill Zobedey
Status: Director

# AMROZ PHARM LIMITED

## Profit and Loss Account

for the Period Ended 30 April 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Turnover |  | 28,775 | 20,362
Cost of sales |  | ( 6,571 ) | ( 2,265 )
Gross Profit or (Loss) |  | 22,204 | 18,097
Administrative Expenses |  | ( 8,437 ) | ( 8,448 )
Operating Profit or (Loss) |  | 13,767 | 9,649
Interest Receivable and Similar Income |  | 55 | 41
Profit or (Loss) Before Tax |  | 13,822 | 9,690
Tax on Profit |  | ( 2,626 ) | ( 1,841 )
Profit or (Loss) for Period |  | 11,196 | 7,849

The notes form part of these financial statements

# AMROZ PHARM LIMITED

## Balance sheet

As at 30 April 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Fixed assets
Total fixed assets: |  | - | -
Current assets
Cash at bank and in hand: |  | 6,439 | 5,106
Total current assets: |  | 6,439 | 5,106
Creditors: amounts falling due within one year: | 4 | ( 4,590 ) | ( 1,953 )
Net current assets (liabilities): |  | 1,849 | 3,153
Total assets less current liabilities: |  | 1,849 | 3,153
Total net assets (liabilities): |  | 1,849 | 3,153

The notes form part of these financial statements

# AMROZ PHARM LIMITED

## Balance sheet continued

As at 30 April 2025

| Notes | 2025 £ | 2024 £
--- | --- | --- | ---
Capital and reserves
Called up share capital: |  | 1 | 1
Profit and loss account: |  | 1,848 | 3,152
Shareholders funds: |  | 1,849 | 3,153

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 7 October 2025
And Signed On Behalf Of The Board By:

Name: Roza Imill Zobedey
Status: Director

The notes form part of these financial statements

# AMROZ PHARM LIMITED

## Notes to the Financial Statements

for the Period Ended 30 April 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

# AMROZ PHARM LIMITED

## Notes to the Financial Statements

for the Period Ended 30 April 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 1 | 1

# AMROZ PHARM LIMITED

## Notes to the Financial Statements

for the Period Ended 30 April 2025

- ## 3. Off balance sheet disclosure

  No

# AMROZ PHARM LIMITED

## Notes to the Financial Statements

for the Period Ended 30 April 2025

## 4.Creditors: amounts falling due within one year note

| 2025 £ | 2024 £
--- | --- | ---
Taxation and social security | 4,467 | 1,841
Other creditors | 123 | 112
Total | 4,590 | 1,953